Evidence map›Paper›PMID 24695530›Full record

ArticlePloS one2014

Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques.

Alessandra Borsetti, Flavia Ferrantelli, Maria T Maggiorella, Leonardo Sernicola, Stefania Bellino, Alessandra Gallinaro, Stefania Farcomeni, Edward T Mee, Nicola J Rose, Aurelio Cafaro and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Alessandra BorsettiNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Flavia FerrantelliNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Maria T MaggiorellaNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Leonardo SernicolaNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Stefania BellinoNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Alessandra GallinaroNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Stefania FarcomeniNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Edward T MeeDivision of Virology, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, South Mimms, Hertfordshire, United Kingdom.
Nicola J RoseDivision of Virology, National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, South Mimms, Hertfordshire, United Kingdom.
Aurelio CafaroNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Fausto TittiNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Barbara EnsoliNational AIDS Center, Istituto Superiore di Sanità, Rome, Italy.
Istituto Superiore di Sanità · ITNational Institute for Biological Standards and Control · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about the effects of Major Histocompatibility Complex (MHC) haplotypes on immunity to primate lentiviruses involving both acquired and innate immune responses. We present statistical evidence of the influence of MHC polymorphism on antiviral immunity of Mauritian cynomolgus macaques (MCM) following simian/human immunodeficiency virus SHIVSF162P4cy infection, involving the production of pro- and anti-inflammatory cytokines and α-defensins, which may modulate acquired immune responses. During the acute phase of infection, IL-10 correlated positively with viral load and negatively with CD4+T cell counts. Furthermore, α-defensins production was directly correlated with plasma viral RNA, particularly at peak of viral load. When the effects of the MHC were analyzed, a significant association between lower anti-Env binding and neutralizing antibody levels with class IB M4 haplotype and with class IA, IB M4 haplotype, respectively, was observed in the post-acute phase. Lower antibody responses may have resulted into a poor control of infection thus explaining the previously reported lower CD4 T cell counts in these monkeys. Class II M3 haplotype displayed significantly lower acute and post-acute IL-10 levels. In addition, significantly lower levels of α-defensins were detected in class IA M3 haplotype monkeys than in non-M3 macaques, in the post-acute phase of infection. These data indicate that the MHC could contribute to the delicate balance of pro-inflammatory mechanisms, particularly with regard to the association between IL-10 and α-defensins in lentivirus infection. Our results show that host genetic background, virological and immunological parameters should be considered for the design and interpretation of HIV-1 vaccine efficacy studies.

Indexed as

alpha-DefensinsAnimalsAntibodies, NeutralizingCD4-Positive T-LymphocytesHaplotypesHIVInterleukin-10MacacaMacaca fascicularisMajor Histocompatibility ComplexMaleRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral Loadalpha-DefensinsAntibodies, NeutralizingInterleukin-10RNA, Viral

Identifiers

PMID24695530
PMCPMC3973703
OpenAlexW2032311493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.